Investors

Predictive Technology Group, Inc.

Business Description

Predictive Technology Group, Inc. (PRED) through its wholly owned subsidiary Predictive Therapeutics, Inc. revolutionizes the treatment of serious and debilitating diseases through the commercialization of novel therapeutics leveraged by proprietary gene-based companion diagnostics. The Company has developed and/or acquired a number of proprietary technologies that open a window into the origin of human disease and the role that genes and their related proteins play in the disease’s onset and progression. PRED uses this information as the cornerstone in the development of new diagnostics that assess a person’s risk of disease and therapeutic products designed to effectively prevent and/or treat the disease.

 

Stock

Financial Reporting/Disclosure
Reporting Status Alternative Reporting Standard
Deregistered a/o Jan 04, 2011
Audited Financials Unaudited
Latest Report Nov 30, 2015 Quarterly Report
CIK 0001382943
Fiscal Year End 8/31
OTC Marketplace OTC Pink Current
Profile Data
SIC – Industry Classification 2835 – Diagnostic substances
Business Status Development Stage Company a/o Sep 16, 2008
Incorporated In: NV, USA
Year of Inc. 2005
Employees 10 a/o Jun 05, 2015
Company Officers/Contacts
Mel Fergusen Secretary, Treasurer
Bradley Robinson President
Company Directors
Mel Fergusen Chairman
Bradley Robinson

Service Providers

Accounting/Auditing Firm
CS&S Enterprises
5840 West Craig Road
Las Vegas, NV, 89130
United States

 

Legal Counsel
Law Office of Robert W. Wright
716 Castro St.
Solana Beach, CA, 92075
United States

 

Investor Relations Firm
Yes International
3419 Virginia Beach Blvd.
#252
Virginia Beach, VA, 23452
United States

Phone: 757-306-6090

Contact Info

2020 General Booth Blvd, Unit 230
Va. Beach, VA 23454

Phone: 717-692-8755

Website: www.predrx.com